Peter Heutink
Overview
Explore the profile of Peter Heutink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
227
Citations
20002
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rambarack N, Fodder K, Murthy M, Toomey C, de Silva R, Heutink P, et al.
bioRxiv
. 2025 Feb;
PMID: 39975316
Frontotemporal Lobar Degeneration (FTLD) represents a spectrum of clinically, genetically, and pathologically heterogeneous neurodegenerative disorders characterised by progressive atrophy of the frontal and temporal lobes of the brain. The two...
2.
Tan M, Iwaki H, Bandres-Ciga S, Sosero Y, Shoai M, Brockmann K, et al.
medRxiv
. 2025 Feb;
PMID: 39974079
Polygenic risk scores (PRS) in Parkinson's disease (PD) are associated with disease risk. Recently, pathway-specific PRS have been created to take advantage of annotations inking variants to biological pathways or...
3.
Yin J, Frick L, Scheidmann M, Liu T, Trevisan C, Dhingra A, et al.
Nat Biomed Eng
. 2024 Dec;
9(1):127-148.
PMID: 39633028
Arrayed CRISPR libraries extend the scope of gene-perturbation screens to non-selectable cell phenotypes. However, library generation requires assembling thousands of vectors expressing single-guide RNAs (sgRNAs). Here, by leveraging massively parallel...
4.
Direct and indirect regulation of β-glucocerebrosidase by the transcription factors USF2 and ONECUT2
Ging K, Frick L, Schlachetzki J, Armani A, Zhu Y, Gilormini P, et al.
NPJ Parkinsons Dis
. 2024 Oct;
10(1):192.
PMID: 39438499
Mutations in GBA1 encoding the lysosomal enzyme β-glucocerebrosidase (GCase) are among the most prevalent genetic susceptibility factors for Parkinson's disease (PD), with 10-30% of carriers developing the disease. To identify...
5.
Sosero Y, Bandres-Ciga S, Ferwerda B, Tocino M, Belloso D, Gomez-Garre P, et al.
Mov Disord
. 2024 Aug;
39(10):1773-1783.
PMID: 39132902
Background: Levodopa-induced dyskinesia (LID) is a common adverse effect of levodopa, one of the main therapeutics used to treat the motor symptoms of Parkinson's disease (PD). Previous evidence suggests a...
6.
Junker J, Lange L, Vollstedt E, Roopnarain K, Doquenia M, Ahmad Annuar A, et al.
Mov Disord
. 2024 Jul;
39(10):1868-1873.
PMID: 39076159
Background: Until recently, about three-quarters of all monogenic Parkinson's disease (PD) studies were performed in European/White ancestry, thereby severely limiting our insights into genotype-phenotype relationships at a global scale. Objective:...
7.
Chatterjee M, Ozdemir S, Fritz C, Mobius W, Kleineidam L, Mandelkow E, et al.
Nat Med
. 2024 Jun;
30(6):1771-1783.
PMID: 38890531
Minimally invasive biomarkers are urgently needed to detect molecular pathology in frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). Here, we show that plasma extracellular vesicles (EVs) contain quantifiable amounts...
8.
Junker J, Lange L, Vollstedt E, Roopnarain K, Doquenia M, Ahmad Annuar A, et al.
medRxiv
. 2024 Mar;
PMID: 38529492
Until recently, about three-quarters of all monogenic Parkinson's disease (PD) studies were performed in European/White ancestry, thereby severely limiting our insights into genotype-phenotype relationships at global scale. The first systematic...
9.
Atasu B, Simon-Sanchez J, Hanagasi H, Bilgic B, Hauser A, Guven G, et al.
J Med Genet
. 2024 Mar;
61(5):443-451.
PMID: 38458754
Background: Dystonia is one of the most common movement disorders. To date, the genetic causes of dystonia in populations of European descent have been extensively studied. However, other populations, particularly...
10.
Screven L, Pantazis C, Andersh K, Hong S, Vitale D, Lara E, et al.
Neuron
. 2024 Feb;
112(5):694-697.
PMID: 38387456
The iDA Project (iPSCs to Study Diversity in Alzheimer's and Alzheimer's Disease-related Dementias) is generating 200 induced pluripotent stem cell lines from Alzheimer's Disease Neuroimaging Initiative participants. These lines are...